Nardeterol

This classification denotes a beta-adrenergic agonist with the molecular formula C20H24FN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 70859437W3, chemically known as benzenemethanol, alpha-(((3-(1h-benzimidazol-1-yl)-1,1-dimethylpropyl)amino)methyl)-2-fluoro-4-hydroxy- but generally known as nardeterol, which bears US NIH Compound Identifier 68918. European Medicines Agency schedules Nardeterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09165MIG. The term NARDETEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). NARDETEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nardeterol under HS 29339990 and SITC 51577. As of Q4 2014, NARDETEROL remains the US FDA Preferred Term for this commodity. Nardeterol bears US NLM identifiers UMLS ID C2698430 and NCI Concept Code C76541. SMILES: FC1C(C(O)CNC(CCN2C3C(NC2)CCCC3)(C)C)CCC(O)C1.